Benedict-Tilmann Berger

29PUBLICATIONS
87CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 13, 2026
Riding toward Selectivity: Optimization of Covalent 7-Azaindole-Based BMX Kinase Inhibitors.

|May 04, 2026
Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137.

|Nov 19, 2025
Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK).

Martina Dettenhöfer, Laura Nadine Tandara, Jennifer Alisa Amrhein

|Jul 02, 2025
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective Inhibitor.

Sebastian Mandel, Thomas Hanke, Niall Prendiville

|Apr 14, 2025
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor.

Sebastian Mandel, Thomas Hanke, Sebastian Mathea

|Jan 08, 2025
Discovery of Carbonic Anhydrase 9 as a Novel CLEC2 Ligand in a Cellular Interactome Screen.

Sebastian Hoffmann, Benedict-Tilman Berger, Liane Rosalie Lucas

Pageof 5

Frequent Collaborators

25 joint publications

Stefan Knapp

12 joint publications

Thomas Hanke

12 joint publications

Susanne Müller

10 joint publications

Lena Marie Berger